tiprankstipranks
Lifestance Health Group (LFST)
NASDAQ:LFST
US Market
Want to see LFST full AI Analyst Report?

Lifestance Health Group (LFST) Ratios

246 Followers

Lifestance Health Group Ratios

LFST's free cash flow for Q2 2026 was $0.35. For the 2026 fiscal year, LFST's free cash flow was decreased by $ and operating cash flow was $0.07. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.38 1.65 1.37 1.11 1.33
Quick Ratio
1.38 1.65 1.37 1.11 1.33
Cash Ratio
0.82 0.99 0.68 0.39 0.62
Solvency Ratio
0.15 0.09 0.02 -0.16 -0.22
Operating Cash Flow Ratio
0.79 0.58 0.47 -0.08 0.30
Short-Term Operating Cash Flow Coverage
4.69 3.21 14.79 -5.77 22.51
Net Current Asset Value
$ -326.38M$ -266.72M$ -359.50M$ -455.31M$ -421.93M
Leverage Ratios
Debt-to-Assets Ratio
0.09 0.09 0.23 0.24 0.22
Debt-to-Equity Ratio
0.14 0.13 0.34 0.36 0.32
Debt-to-Capital Ratio
0.12 0.11 0.25 0.26 0.24
Long-Term Debt-to-Capital Ratio
0.09 0.09 0.16 0.16 0.13
Financial Leverage Ratio
1.48 1.45 1.46 1.48 1.43
Debt Service Coverage Ratio
2.04 1.33 1.19 -3.50 -5.68
Interest Coverage Ratio
7.75 2.07 -1.19 -8.91 -10.55
Debt to Market Cap
0.04 0.07 0.10 0.10 0.13
Interest Debt Per Share
0.55 0.53 1.35 1.45 1.40
Net Debt to EBITDA
-0.19 -0.69 8.29 -4.12 -2.58
Profitability Margins
Gross Profit Margin
33.56%32.37%32.17%28.62%27.57%
EBIT Margin
4.87%1.69%-2.48%-17.56%-24.76%
EBITDA Margin
8.31%5.53%3.19%-9.94%-16.71%
Operating Profit Margin
4.95%1.70%-2.53%-17.92%-24.45%
Pretax Profit Margin
4.23%0.87%-4.61%-19.57%-27.08%
Net Profit Margin
3.19%0.68%-4.59%-17.64%-25.08%
Continuous Operations Profit Margin
3.19%0.68%-4.59%-17.64%-25.08%
Net Income Per EBT
75.53%78.16%99.70%90.16%92.62%
EBT Per EBIT
85.42%51.20%182.24%109.23%110.73%
Return on Assets (ROA)
2.32%0.44%-2.71%-8.83%-9.92%
Return on Equity (ROE)
3.39%0.64%-3.97%-13.04%-14.19%
Return on Capital Employed (ROCE)
4.11%1.24%-1.67%-9.92%-10.52%
Return on Invested Capital (ROIC)
3.03%0.94%-1.62%-8.72%-9.55%
Return on Tangible Assets
7.19%1.32%-9.06%-31.28%-33.81%
Earnings Yield
1.04%0.36%-2.06%-6.47%-12.28%
Efficiency Ratios
Receivables Turnover
14.28 14.88 9.48 8.40 8.47
Payables Turnover
95.27 157.33 117.17 32.47 25.54
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
4.93 4.58 3.99 2.94 2.18
Asset Turnover
0.73 0.65 0.59 0.50 0.40
Working Capital Turnover Ratio
14.45 11.49 23.50 26.36 8.31
Cash Conversion Cycle
21.72 22.21 35.41 32.20 28.82
Days of Sales Outstanding
25.55 24.53 38.52 43.44 43.10
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
3.83 2.32 3.12 11.24 14.29
Operating Cycle
25.55 24.53 38.52 43.44 43.10
Cash Flow Ratios
Operating Cash Flow Per Share
0.57 0.38 0.28 -0.05 0.15
Free Cash Flow Per Share
0.55 0.29 0.23 -0.16 -0.07
CapEx Per Share
0.02 0.09 0.06 0.11 0.22
Free Cash Flow to Operating Cash Flow
0.96 0.75 0.80 3.40 -0.50
Dividend Paid and CapEx Coverage Ratio
27.80 4.05 4.97 -0.42 0.67
Capital Expenditure Coverage Ratio
27.80 4.05 4.97 -0.42 0.67
Operating Cash Flow Coverage Ratio
1.09 0.75 0.22 -0.03 0.11
Operating Cash Flow to Sales Ratio
0.14 0.10 0.09 -0.02 0.06
Free Cash Flow Yield
4.25%4.05%3.07%-2.00%-1.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
97.77 234.67 -49.13 -15.45 -8.14
Price-to-Sales (P/S) Ratio
3.12 1.91 2.23 2.73 2.04
Price-to-Book (P/B) Ratio
3.31 1.79 1.93 2.01 1.16
Price-to-Free Cash Flow (P/FCF) Ratio
23.51 24.70 32.61 -50.12 -66.31
Price-to-Operating Cash Flow Ratio
22.41 18.59 26.05 -170.41 33.25
Price-to-Earnings Growth (PEG) Ratio
0.04 -1.96 0.70 0.94 0.19
Price-to-Fair Value
3.31 1.79 1.93 2.01 1.16
Enterprise Value Multiple
37.31 33.80 78.37 -31.54 -14.80
Enterprise Value
4.91B 2.66B 3.12B 3.31B 2.13B
EV to EBITDA
37.31 33.80 78.37 -31.54 -14.80
EV to Sales
3.10 1.87 2.50 3.13 2.47
EV to Free Cash Flow
23.39 24.20 36.47 -57.65 -80.30
EV to Operating Cash Flow
22.55 18.22 29.13 -196.01 40.26
Tangible Book Value Per Share
>-0.01 0.13 -0.10 -0.23 -0.05
Shareholders’ Equity Per Share
3.85 3.94 3.81 3.89 4.27
Tax and Other Ratios
Effective Tax Rate
0.24 0.22 <0.01 0.10 0.07
Revenue Per Share
4.13 3.69 3.30 2.87 2.42
Net Income Per Share
0.13 0.03 -0.15 -0.51 -0.61
Tax Burden
0.76 0.78 1.00 0.90 0.93
Interest Burden
0.87 0.51 1.85 1.11 1.09
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.25 0.27 0.29 0.39 0.44
Stock-Based Compensation to Revenue
0.04 0.05 0.06 0.09 0.22
Income Quality
4.31 15.12 -1.87 0.09 -0.24
Currency in USD